Orchestra BioMed Holdings Operating Income

Orchestra BioMed Holdings (OBIO) currently reports a operating income of $-55M as of March 2026. That compares with $-69M in the prior-year period — up 20.1% year over year. Use the charts on this page to explore Orchestra BioMed Holdings's operating income history and peer comparisons.

Orchestra BioMed Holdings's operating income increased from $-69M to $-55M — a 20.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Orchestra BioMed Holdings reported $-55M in operating income as of March 2026. That compares with $-69M in the prior-year period — up 20.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-55M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Orchestra BioMed Holdings, and consider following OBIO for alerts when major investors trade the stock.